GLYC has started trading in the open market.
Visit the Detailed Quote page for the latest information.

GLYC  GlycoMimetics

 
NASDAQ
  • Price Range
    $8.00 - $8.00
  • Expected Date
    Week of 1/6
  • Shares Offered
    7.0 M
  • View Prospectus

Company Summary

We are a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using our expertise in carbohydrate chemistry and knowledge of carbohydrate biology, we are developing a pipeline of proprietary glycomimetics that inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. We believe this represents an innovative approach to drug discovery to treat a wide range of diseases.

IPO Details

Price Range$8.00 - $8.00
Expected To Trade1/10/2014
Shares Offered7.0 M
Est. $ Volume$56 M
Market Cap$130.4 M
Revenues (TTM)$7.8 M
Net Income (TTM)-$6.1 M
Manager(s)
Jefferies/ Barclays
Co-Manager(s)
Stifel/ Canaccord Genuity
||AAA
Company Profile
Address401 Professional Drive, Suite 250, Gaithersburg, MD 20879 , US
Phone240-243-1201
Number of Employees28
IndustryHealth Care
Website
IPO Center Quick Links